Innovative Transdermal Technologies
and Patient Focused Pharmaceutical products

About Us

At Nutriband and our subsidiaries,  our core focus is to use innovative drug delivery systems and devices to improve patient outcomes, specifically targeting the Global Opioid epidemic. Fentanyl and other opioid based transdermal medications unfortunately play a role in a significant number of opioid deaths each year with no solution currently available. Working with our Clinical subsidiary 4P Therapeutics we have developed a technology called AVERSA which we believe with FDA approval will revolutionize the safety standard for these medications and save countless lives per year.

Research & Innovation

Through our Clinical Subsidiary 4P Therapeutics,Our Company has capabilities for developing pharmaceutical products from pre-clinical testing to clinical manufacturing and early stage clinical development (Phase I/II). A key company focus and area of expertise at 4P is in the development of transdermal products for currently injected compounds, including proteins, peptides, macromolecules and biologics. Transdermal delivery of commercially available drugs or biologics that are typically delivered via injection has the potential to improve safety, efficacy and therapeutic outcomes associated with these treatments.

4P Therapeutics
4P Therapeutics is a clinical subsidiary of Nutriband Inc. (NTRB) focused on the research and development of novel drug delivery technologies and therapeutics. 4P develops products that meet the needs of patients, physicians and payers.
Pocono Pharmaceutical
Pocono Pharmaceutical is our contract manufacturing subsidiary in the area of coated materials, Consulting, Formulations and manufacturing.
Nutriband Investors
Nutriband is a pioneer in the science of using novel transdermal solutions, and other innovative technologies to offer alternatives to invasive drug administration.
Careers at Nutriband
At Nutriband Inc, we’re driven to significantly improve the lives of everyone. Science is the foundation of our company.

Emerging Transdermal Technologies, Emerging Transdermal Technology, Innovative Pharmaceutical products, Innovative Transdermal Technologies, Patient Focused Pharmaceutical products, Transdermal Bio Products, Transdermal Compounds, Transdermal drug delivery, Transdermal drug products, Transdermal Macromolecules, Transdermal Medication, Transdermal Medications, Transdermal Patch Technology, Transdermal Patches, Transdermal Patient Focused Pharmaceutical products, Transdermal Pharmaceutical products, Transdermal Pharmaceuticals, Transdermal polymeric drug, Transdermal polymeric drugs, Transdermal Proteins, Transdermal Solutions, Transdermal Technologies, Transdermal Technology